The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Historique:
received: 08 07 2020
revised: 23 12 2020
accepted: 30 12 2020
pubmed: 16 4 2021
medline: 25 8 2021
entrez: 15 4 2021
Statut: ppublish

Résumé

Ubiquitin is a versatile posttranslational modification, which is covalently attached to protein targets either as a single moiety or as a ubiquitin chain. In contrast to K48 and K63-linked chains, which have been extensively studied, the regulation and function of most atypical ubiquitin chains are only starting to emerge. The deubiquitinase TRABID/ZRANB1 is tuned for the recognition and cleavage of K29 and K33-linked chains. Yet, substrates of TRABID and the cellular functions of these atypical ubiquitin signals remain unclear. We determined the interactome of two TRABID constructs rendered catalytic dead either through a point mutation in the catalytic cysteine residue or through removal of the OTU catalytic domain. We identified 50 proteins trapped by both constructs and which therefore represent candidate substrates of TRABID. The E3 ubiquitin ligase HECTD1 was then validated as a substrate of TRABID and used UbiCREST and Ub-AQUA proteomics to show that HECTD1 preferentially assembles K29- and K48-linked ubiquitin chains. Further in vitro autoubiquitination assays using ubiquitin mutants established that while HECTD1 can assemble short homotypic K29 and K48-linked chains, it requires branching at K29/K48 in order to achieve its full ubiquitin ligase activity. We next used transient knockdown and genetic knockout of TRABID in mammalian cells in order to determine the functional relationship between TRABID and HECTD1. This revealed that upon TRABID depletion, HECTD1 is readily degraded. Thus, this study identifies HECTD1 as a mammalian E3 ligase that assembles branched K29/K48 chains and also establishes TRABID-HECTD1 as a DUB/E3 pair regulating K29 linkages.

Identifiants

pubmed: 33853758
pii: S0021-9258(21)00011-9
doi: 10.1074/jbc.RA120.015162
pmc: PMC7948964
pii:
doi:

Substances chimiques

Ubiquitin 0
HectD1 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27
Endopeptidases EC 3.4.-
ZRANB1 protein, human EC 3.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100246

Subventions

Organisme : Medical Research Council
ID : MC_U105192713
Pays : United Kingdom
Organisme : Medical Research Council
ID : U105192713
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

Nat Commun. 2018 Feb 6;9(1):524
pubmed: 29410401
Mol Cell. 2017 May 4;66(3):345-357.e6
pubmed: 28475870
Nat Struct Mol Biol. 2011 Dec 11;19(1):62-71
pubmed: 22157957
Cell. 2016 Jul 14;166(2):394-407
pubmed: 27321670
J Biol Chem. 1985 Feb 10;260(3):1573-81
pubmed: 2981864
Autophagy. 2019 Jul;15(7):1130-1149
pubmed: 30686098
Biochem J. 2015 Apr 15;467(2):345-52
pubmed: 25723849
Chembiochem. 2017 Jul 18;18(14):1415-1427
pubmed: 28425671
Int J Biochem Cell Biol. 2013 Aug;45(8):1833-42
pubmed: 23732108
Cell. 1999 Mar 5;96(5):645-53
pubmed: 10089880
Trends Cell Biol. 2019 Sep;29(9):704-716
pubmed: 31300189
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4606-10
pubmed: 1647011
Mol Cell. 2019 Jan 17;73(2):377-389.e11
pubmed: 30581143
Mol Cell Proteomics. 2012 Aug;11(8):329-41
pubmed: 22496338
Nat Chem Biol. 2010 Oct;6(10):750-7
pubmed: 20802491
Cell Rep. 2018 Apr 17;23(3):823-837
pubmed: 29669287
J Biol Chem. 2015 Feb 20;290(8):4688-4704
pubmed: 25389291
J Biol Chem. 2013 Feb 1;288(5):2976-85
pubmed: 23184937
Science. 2004 May 28;304(5675):1328-31
pubmed: 15105460
Mol Cell Proteomics. 2011 May;10(5):R110.003871
pubmed: 20823120
EMBO J. 2005 Jul 6;24(13):2414-24
pubmed: 15933713
Anal Chem. 2002 Oct 15;74(20):5383-92
pubmed: 12403597
J Cell Biol. 2002 Apr 29;157(3):417-27
pubmed: 11980917
PLoS Genet. 2014 Feb 20;10(2):e1004117
pubmed: 24586180
Nature. 1991 Jan 10;349(6305):132-8
pubmed: 1846030
Nat Protoc. 2015 Mar;10(3):426-41
pubmed: 25675208
J Biol Chem. 1983 Jul 10;258(13):8206-14
pubmed: 6305978
J Biol Chem. 1999 Sep 17;274(38):27299-306
pubmed: 10480950
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15722-7
pubmed: 24019463
Cell Death Differ. 2019 Jan;26(2):306-320
pubmed: 29748601
Mol Cell. 1998 Jan;1(2):193-202
pubmed: 9659916
Methods Enzymol. 2005;399:21-36
pubmed: 16338346
BMC Chem Biol. 2012 May 14;12:4
pubmed: 22584113
Science. 1989 Mar 24;243(4898):1576-83
pubmed: 2538923
Cell Rep. 2018 Jan 23;22(4):1016-1030
pubmed: 29386124
J Biol Chem. 1982 Mar 10;257(5):2537-42
pubmed: 6277904
J Biol Chem. 2003 Jun 20;278(25):23180-6
pubmed: 12682062
Nat Commun. 2014 Aug 27;5:4763
pubmed: 25159004
Cell. 2006 Jan 13;124(1):89-103
pubmed: 16413484
Nature. 1997 Feb 20;385(6618):737-40
pubmed: 9034192
Nat Rev Mol Cell Biol. 2012 Jul 23;13(8):508-23
pubmed: 22820888
Cell. 2009 Jul 23;138(2):389-403
pubmed: 19615732
Nat Commun. 2017 Feb 06;8:14274
pubmed: 28165462
Cell. 2016 Dec 1;167(6):1636-1649.e13
pubmed: 27912065
J Virol. 2000 Jul;74(14):6408-17
pubmed: 10864652
Elife. 2017 Mar 15;6:
pubmed: 28296634
J Biol Chem. 2001 Jun 8;276(23):19871-8
pubmed: 11278995
Nature. 2011 Jun 2;474(7349):105-8
pubmed: 21532592
Eur J Biochem. 1998 Jun 15;254(3):643-9
pubmed: 9688277
J Biol Chem. 2002 Feb 15;277(7):4656-62
pubmed: 11739384
Mol Cell Proteomics. 2009 Jan;8(1):157-71
pubmed: 18782753
EMBO Rep. 2006 Nov;7(11):1147-53
pubmed: 17028573
Mol Cell. 2016 Oct 20;64(2):251-266
pubmed: 27746020
J Biol Chem. 1995 Jul 21;270(29):17442-56
pubmed: 7615550
Mol Cancer Res. 2008 Sep;6(9):1385-96
pubmed: 18819927
Chem Biol. 2013 Dec 19;20(12):1447-55
pubmed: 24290882
J Biol Chem. 2007 Feb 9;282(6):4102-12
pubmed: 17135271
Nature. 2004 Aug 5;430(7000):694-9
pubmed: 15258597
Nature. 2019 Aug;572(7770):533-537
pubmed: 31413367
Nucleic Acids Res. 1995 Dec 25;23(24):5080-1
pubmed: 8559668
EMBO J. 2005 Nov 2;24(21):3747-56
pubmed: 16211010
Proc Natl Acad Sci U S A. 1979 Jul;76(7):3107-10
pubmed: 290989
Methods Mol Biol. 2019;1977:25-34
pubmed: 30980320
Nat Immunol. 2016 Mar;17(3):259-68
pubmed: 26808229
Nat Cell Biol. 2006 Jul;8(7):700-10
pubmed: 16799550
Nat Protoc. 2015 Feb;10(2):349-361
pubmed: 25633630
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2228-33
pubmed: 21266548
Mol Cell. 2007 Jun 22;26(6):891-8
pubmed: 17588522
Mol Cell. 2017 May 18;66(4):488-502.e7
pubmed: 28525741
Nat Chem Biol. 2016 May;12(5):324-31
pubmed: 26928937
Mol Cell. 2015 Apr 2;58(1):83-94
pubmed: 25752573
EMBO J. 2006 Apr 19;25(8):1710-9
pubmed: 16601690
EMBO J. 2004 Apr 7;23(7):1411-21
pubmed: 15029239
Mol Cell Proteomics. 2011 May;10(5):M110.003756
pubmed: 21048196
Mol Cell. 2015 Apr 2;58(1):95-109
pubmed: 25752577
Cell. 2008 May 16;133(4):653-65
pubmed: 18485873
EMBO Rep. 2009 May;10(5):466-73
pubmed: 19373254
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Genes Dev. 2008 Feb 15;22(4):528-42
pubmed: 18281465
EMBO J. 2014 May 16;33(10):1159-76
pubmed: 24811749
Mol Cell. 2020 Dec 3;80(5):796-809.e9
pubmed: 33156996
Nature. 2014 Jun 19;510(7505):370-5
pubmed: 24896179
EMBO J. 2020 Nov 16;39(22):e104863
pubmed: 33015833
Cell. 2013 Jul 3;154(1):169-84
pubmed: 23827681
Mol Cell. 2015 Jul 16;59(2):188-202
pubmed: 26166704
J Cell Biol. 1992 Oct;119(2):301-11
pubmed: 1400575
Cell. 2009 Apr 3;137(1):133-45
pubmed: 19345192
FEBS Lett. 2016 Dec;590(23):4213-4222
pubmed: 27800609
J Cell Sci. 2009 Jul 15;122(Pt 14):2325-9
pubmed: 19571111
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18213-8
pubmed: 19822757
Elife. 2013 Aug 08;2:e00828
pubmed: 23936628
Cell. 2006 Dec 29;127(7):1401-13
pubmed: 17190603
Cell Metab. 2014 Apr 1;19(4):642-52
pubmed: 24703696
Science. 2007 Jan 12;315(5809):201-5
pubmed: 17218518
J Cell Biol. 2012 Mar 19;196(6):789-800
pubmed: 22431752
J Biol Chem. 2013 Feb 8;288(6):3753-67
pubmed: 23277359
Cell Rep. 2016 Jul 26;16(4):1180-1193
pubmed: 27425610
Biochem Soc Trans. 2009 Oct;37(Pt 5):937-53
pubmed: 19754430
Biochemistry. 2014 Aug 5;53(30):4979-89
pubmed: 25023374
Cell. 1999 Mar 5;96(5):635-44
pubmed: 10089879
Nat Cell Biol. 2016 May 27;18(6):579-86
pubmed: 27230526
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1365-8
pubmed: 6769112
Mol Cell Biol. 2013 Oct;33(20):4095-105
pubmed: 23959799
Cell. 2014 May 8;157(4):910-21
pubmed: 24813613
Anal Chem. 2017 Apr 18;89(8):4428-4434
pubmed: 28291339
Nat Genet. 2016 Nov;48(11):1349-1358
pubmed: 27694961

Auteurs

Lee D Harris (LD)

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.

Janic Le Pen (J)

MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Nico Scholz (N)

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.

Juliusz Mieszczanek (J)

MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Natalie Vaughan (N)

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.

Simon Davis (S)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Georgina Berridge (G)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Benedikt M Kessler (BM)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Mariann Bienz (M)

MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Julien D F Licchesi (JDF)

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom. Electronic address: j.licchesi@bath.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH